Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG
Issued Date
2026-01-01
Resource Type
ISSN
18696953
eISSN
18696961
Scopus ID
2-s2.0-105038160149
Journal Title
Diabetes Therapy
Rights Holder(s)
SCOPUS
Bibliographic Citation
Diabetes Therapy (2026)
Suggested Citation
Chan S.P., Tarigan T.J.E., Bansal B., Fontanilla J.A.C., Zainudin S., Shin U., Likitmaskul S. Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG. Diabetes Therapy (2026). doi:10.1007/s13300-026-01867-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116749
Title
Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG
Corresponding Author(s)
Other Contributor(s)
Abstract
Introduction: Diabetes mellitus presents a growing public health challenge across geographies including Asia, particularly in countries where blood glucose monitoring (BGM)—referring to capillary finger-prick self-monitoring of blood glucose (SMBG) using a meter and test strips—is underutilized. Having evolved and improved over recent decades, glucose monitoring (GM)—including SMBG and continuous glucose monitoring (CGM)—has become an essential tool for effective diabetes management, yet remains underutilized because of systemic, economic, and educational barriers. This work synthesizes expert insights and published evidence to develop best practice recommendations for BGM. Methods: A targeted literature review (TLR) was conducted across five thematic domains: monitoring practices, clinical decision-making, patient engagement and adherence, technology and innovation, and policy and reimbursement. Insights were complemented by a structured expert forum involving clinicians from seven Asian countries, underscoring larger implications in geographies where SMBG remains underutilized within the diabetes care continuum. The forum highlighted disparities in device access, affordability, and insurance coverage, and emphasized the need for structured diabetes self-management education (DSME) and digital integration. Results: Findings support the use of structured SMBG for non-insulin-treated type 2 diabetes and CGM for insulin-treated individuals and those at risk of hypoglycemia. Evidence from the literature review also highlighted the importance of proper SMBG technique, with common errors such as inadequate handwashing, repeated lancet use, and excessive finger squeezing contributing to inaccurate readings and finger-site injuries. Hybrid models combining CGM and SMBG for calibration or confirmation are pragmatic solutions balancing clinical utility and affordability. Digital platforms, AI-driven analytics, and mobile apps enhance patient engagement and glycemic control but face challenges of scalability and regulation. Conclusion: Policy reforms, including inclusion of BGM in national health benefit packages, expanded insurance coverage, and public–private partnerships, are critical to improving access. The recommendations advocate for personalized, context-specific monitoring strategies that balance clinical efficacy with affordability and infrastructure realities. This consensus-based framework aims to guide healthcare professionals in optimizing BGM practices and improving long-term outcomes for people living with diabetes. FITTER BiG is a new extension of the long-standing FITTER initiative, which has provided insulin injection technique recommendations for more than two decades. FITTER BiG complements this work by focusing specifically on best practice recommendations for blood glucose monitoring. FITTER BiG will provide BGM-specific recommendations designed to complement the injection technique guidance outlined in the FITTER Forward consensus statement (Klonoff et al. Mayo Clin Proc 100:682–699, 2025 [1]).